Schematherapie (ST) ist ein integrativer Therapieansatz zur Behandlung chronischer Probleme mit nachgewiesener Effektivität in der Behandlung von Persönlichkeitsstörungen. Dieser Artikel beschreibt die Anwendung der ST bei chronischer Depression. Dazu präsentieren wir eine Literaturübersicht zu Risikofaktoren, die chronischer Depression zugrunde liegen. Zudem wird ein Modell der chronischen Depression vorgestellt, in dem die Interaktion der empirisch nachgewiesenen Risikofaktoren (frühe negative Erfahrungen, kognitive Faktoren, Persönlichkeitspathologie, interpersonelle Faktoren) beschrieben wird. Schließlich stellen wir ein Protokoll zur Behandlung der chronischen Depression vor, das die Techniken beschreibt, die in der ST angewandt werden, um die zugrunde liegenden Risikofaktoren zu bearbeiten. Im Hinblick auf den heutigen Stand der empirischen Evidenz bezüglich der Risikofaktoren chronischer Depressionen scheint ST ein vielversprechender neuer Behandlungsansatz bei chronischer Depression zu sein, da er direkt an den Risikofaktoren ansetzt.

Keywords:
Chronische Depression, Schematherapie, Frühe Maladaptive Schemata, Risikofaktoren
1.
Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, Panzarella C, Rose DT: Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. J Abnorm Psychol 2006;115:145-156.
2.
Anderson RL, Klein DN, Riso LP, Ouimette PC, Lizardi H, Schwartz JE: The subaffective-character spectrum subtyping distinction in primary early-onset dysthymia: a clinical and family study. J Affect Disord 1996;26:38:13-22.
3.
Arnow BA, Constantino MJ: Effectiveness of psychotherapy and combination treatment for chronic depression. J Clin Psychol 2003;59:893-905.
4.
Bagby R, Psych C, Quilty LC, Ryder A: Personality and depression. Can J Psychiatry 2008;53:14-25.
5.
Bamelis LL, Evers SM, Spinhoven P, Arntz A: Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. Am J Psychiatry 2014;171:305-322.
6.
Barrett MS, Barber JP: Interpersonal profiles in major depressive disorder. J Clin Psychol 2007;63:247-266.
7.
Beck AT, Beck, JS: The Personality Belief Questionnaire. Unpublished assessment instrument. Bala Cynwyd, Beck Institute for Cognitive Therapy and Research, 1991.
8.
Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979.
9.
Brewin CR, Wheatley J, Patel T, Fearon P, Hackmann A, Wells A, Fisher P, Myers S: Imagery rescripting as a brief stand-alone treatment for depressed patients with intrusive memories. Behav Res Ther 2009;47:569-576.
10.
Brown GW, Craig TKJ, Harris TO, Handle RV, Harvey AL: Development of a retrospective interview measure of parental maltreatment using the Childhood Experience of Care and Abuse (CECA) instrument - A life-course study of adult chronic depression - 1. J Affect Disord 2007;103:205-215.
11.
Brown GW, Moran P: Clinical and psychosocial origins of chronic depressive episodes. I: A community survey. Br J Psychiatry 1994;165:447-456.
12.
Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D: Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002;68:317-330.
13.
Burcusa SL, Iacono WG: Risk for recurrence in depression. Clin Psychol Rev 2007;27:959-985.
14.
Carvalho JP, Hopko DR: Behavioral theory of depression: reinforcement as a mediating variable between avoidance and depression. J Behav Ther Exp Psychiatry 2011;42:154-162.
15.
Castonguay LG, Goldfried MR, Wiser S, Raue PJ, Hayes AM: Predicting the effect of cognitive therapy for depression: a study of unique and common factors. J Consult Clin Psychol 1996;64:497-504.
16.
Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF: Adverse childhood experiences and the risk of depressive disorders in adult-hood. J Affect Disord 2004;82:217-225.
17.
Clark DM, Beck AT: Scientific Foundations of Cognitive Theory and Therapy for Depression. New York, Wiley, 1999.
18.
Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Andersson G: Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev 2010;30:51-62.
19.
Cukor D, McGinn LK: History of child abuse and severity of adult depression: the mediating role of cognitive schema. J Child Sex Abus 2006;15:19-34.
20.
Dent J, Teasdale JD: Negative cognition and the persistence of depression. J Abnorm Psychol 1988;97:29-34.
21.
Ellison JA, Greenberg LS, Goldman RN, Angus L: Maintenance of gains following experiential therapies for depression. J Consult Clin Psychol 2009;77: 103-112.
22.
Farmer R, Nelson-Gray RO: Personality disorders and depression: hypothetical relations, empirical findings, and methodological considerations. Clin Psychol Rev 1990;10:453-476.
23.
Farrell JM, Shaw IA, Webber MA: A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry 2009; 40:317-328.
24.
Fava M, Alpert J, Borus J, Nierenberg A, Pava J, Rosenbaum J: Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry 1996;153:1308-1312.
25.
Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RMA, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB: Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biol Psychiatry 2003;54:806-817.
26.
Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T, Kremers I, Nadort M, Arntz, A: Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006;63:649-658.
27.
Greenberg LS, Watson JC: Emotion-Focused Therapy for Depression. Washington, American Psychological Association, 2006.
28.
Harris AE, Curtin L: Parental perceptions, early maladaptive schemas, and depressive symptoms in young adults. Cognitive Ther Res 2002;26:405-416.
29.
Hayden EP, Klein DN: Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. Am J Psychiatry 2001; 158:1864-1870.
30.
Holmstrand C, Engström G, Träskman-Bendz L: Disentangling dysthymia from major depressive disorder in suicide attempters' suicidality, comorbidity and symptomatology. Nord J Psychiatry 2008;62:25-31.
31.
Hölzel L, Härter M, Reese C, Kriston L: Risk factors for chronic depression - a systematic review. J Affect Disord 2011;129:1-13.
32.
Howland RH: Chronic depression. Hosp Community Psychiatry 1993;44:633-639.
33.
Iacoviello BM, Alloy LB, Abramson LY, Whitehouse WG, Hogan ME: The course of depression in individuals at high and low cognitive risk for depression: a prospective study. J ffect Disord 2006;93:61-69.
34.
Ilardi SS, Craighead WE, Evans DD: Modeling relapse in unipolar depression: the effects of dysfunctional cognitions and personality disorders. J Consult Clin Psychol 1997;65:381-391.
35.
Ingram RE: Origins of cognitive vulnerability to depression. Cognitive Ther Res 2003;27:77-88.
36.
James IA, Southam L, Blackburn IM: Schemas revisited. Clin Psychol Psychother 2004;11:369-377.
37.
Joiner TE: Depression's vicious scree: self-propagating and erosive processes in depression chronicity. Clin Psychol Sci Pr 2000;7: 203-218.
38.
Kaplan MJ, Klinetob NA: Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. J Nerv Ment Dis 2000;188:596-601.
39.
Keller MB, Hanks DL, Kocsis JH, Klein DN: Course and natural history of chronic depression; in Kocsis JH, Klein DN (eds): Diagnosis and Treatment of Chronic Depression. New York, Guilford Press, 1995, pp 58-72.
40.
Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470.
41.
Klein DN: Chronic depression: diagnosis and classification. Curr Dir Psychol Sci 2010;19: 96-100.
42.
Klein DN, Arnow BA, Barkin JL, Dowling F, Kocsis JH, Leon AC, Manber R, Rothbaum BO, Trivedi MH, Wisniewski SR: Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depress Anxiety 2009;26:701-710.
43.
Klein DN, Santiago N: Dysthymia and chronic depression: introduction, classification, risk factors, and course. J Clin Psychol 2003;59:807-816.
44.
Klerman G, Weissman M, Rounsaville B, Chevron E: Interpersonal Psychotherapy of Depression. New York, Basic Books, 1984.
45.
Kocsis JH: Pharmacotherapy for chronic depression. J Clin Psychol 2003;59:885-892.
46.
Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME; REVAMP Investigators: Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: The REVAMP Trial. Arch Gen Psychiatry 2009;66:1178-1188.
47.
Kuyken W, Kurzer N, DeRubeis RJ, Beck AT, Brown GK: Response to cognitive therapy in depression: the role of maladaptive beliefs and personality disorders. J Consult Clin Psychol 2001;69:560-566.
48.
Lewinsohn PM, Joiner TE Jr, Rohde P: Evaluation of cognitive diathesis-stress models in predicting major depressive disorder in adolescents. J Abnorm Psychol 2001;110:203-215.
49.
Lewinsohn PM, Steinmetz JL, Larson DW, Franklin J: Depression-related cognitions: antecedent or consequence? J Abnorm Psychol 1981;90:213-219.
50.
Ley P, Helbig-Lang S, Czilwik S, Lang T, Worlitz A, Brücher K, Petermann F: Phenomenological differences between acute and chronic forms of major depression in inpatients. Nord J Psychiatry 2011;65:330-337.
51.
Lizardi H, Klein DN: Parental psychopathology and reports of the childhood home environment in adults with early-onset dysthymic disorder. J Nerv Ment Dis 2000;188:63-70.
52.
Lumley MN, Harkness KL: Specificity in the relations among childhood adversity, early maladaptive schemas, and symptom profiles in adolescent depression. Cognitive Ther Res 2007;31:639-657.
53.
Lumley MN, Harkness KL: Childhood maltreatment and depressotypic cognitive organization. Cognitive Ther Res 2009;33:511-522.
54.
Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME: Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord 2009;117:174-179.
55.
Manber R, Kraemer HC, Arnow BA, Trivedi MH, Rush AJ, Thase ME, Rothbaum BO, Klein DN, Kocsis JH, Gelenberg AJ, Keller ME: Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. J Consult Clin Psychol 2008;76:459-467.
56.
McCullough JP Jr: Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP). J Clin Psychol 2003;59: 833-846.
57.
McCullough JP Jr, Klein DN, Borian FE, Howland RH, Riso LP, Keller MB, Banks PLC: Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol 2003;112: 614-622.
58.
McGinn LK, Cukor D, Sanderson WC: The relationship between parenting style, cognitive style, and anxiety and depression: does increased early adversity influence symptom severity through the mediating role of cognitive style? Cognitive Ther Res 2005;29:219-242.
59.
Mongrain M, Blackburn S: Cognitive vulnerability, lifetime risk, and the recurrence of major depression in graduate students. Cognitive Ther Res 2005; 29:747-768.
60.
Nadort M, Arntz A, Smit JH, Giesen-Bloo J, Eikelenboom M, Spinhoven P, van Asselt T, Wensing M, van Dyck R: Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: a randomized trial. Behav Res Ther 2009;47:961-973.
61.
Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP, Weiss PM, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA 2003;100: 14293-14296.
62.
Newton-Howes G, Tyrer P, Johnson T: Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 2006; 188:13-20.
63.
Nordahl HM, Nysaeter TE: Schema therapy for patients with borderline personality disorder: a single case series. J Behav Ther Exp Psychiatry 2005;36: 254-264.
64.
Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C: Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004;61:714-719.
65.
Pepper C, Klein D, Anderson R, Riso L, Ouimette P, Lizardi H: DSM-III-R axis II comorbidity in dysthymia and major depression. Am J Psychiatry 1995;152:239-247.
66.
Renner F, Jarrett RB, Vittengl JR, Barrett MS, Clark LA, Thase ME: Interpersonal problems as predictors of therapeutic alliance and symptom improvement in cognitive therapy for depression. J Affect Disord 2012b;138:458-467.
67.
Renner F, Lobbestael J, Peeters F, Arntz A, Huibers M: Early maladaptive schemas in depressed patients: stability and relation with depressive symptoms over the course of treatment. J Affect Disord 2012a;136:581-590.
68.
Riso LP, du Toit PL, Blandino JA, Penna S, Dacey S, Duin JS, Pacoe EM, Grant MM, Ulmer CS: Cognitive aspects of chronic depression. J Abnorm Psychol 2003;112:72-80.
69.
Riso LP, Newman CF: Cognitive therapy for chronic depression. J Clin Psychol 2003;59:817-831.
70.
Rothschild L, Zimmerman M: Personality disorders and the duration of depressive episode: a retrospective study. J Personal Disord 2002;16:293-303.
71.
Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RMA, Keller MB: Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry 2003;64:554-561.
72.
Schramm E, Zobel I, Dykierek P, Kech S, Brakemeier E-L, Külz A, Berger M: Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study. J Affect Disord 2011;129: 109-116.
73.
Segal ZV: Appraisal of the self-schema construct in cognitive models of depression. Psychol Bull 1988;103:147-162.
74.
Skodol AE, Grilo CM, Keyes KM, Geier T, Grant BF, Hasin DS: Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry 2011; 168:257-264.
75.
Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A: Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006;9: 193-200.
76.
Stulz N, Thase ME, Klein DN, Manber R, Crits-Christoph P: Differential effects of treatments for chronic depression: a latent growth model reanalysis. J Consult Clin Psychol 2010;78:409-419.
77.
Teasdale JD: Emotional processing, three modes of mind and the prevention of relapse in depression. Behav Res Ther 1999;37:S53-S77.
78.
Thase ME: When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder? Psychiatr Q 1999;70:333-346.
79.
Thase ME, Greenhouse JB, Frank E, Reynolds CF III, Pilkonis PA, Hurley K, Grochocinski V, Kupfer DJ: Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-1015.
80.
Torpey DC, Klein DN: Chronic depression: update on classification and treatment. Curr Psychiatry Rep 2008;10:458-464.
81.
Watson JC, Bedard DL: Clients' emotional processing in psychotherapy: a comparison between cognitive-behavioral and process-experiential therapies. J Consult Clin Psychol 2006;74:152-159.
82.
Watson JC, Gordon LB, Stermac L, Kalogerakos F, Steckley P: Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol 2003;71:773-781.
83.
Wells KB, Burnam MA, Rogers W, Hays R: The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psychiatry 1992;49:788-794.
84.
Young JE, Klosko J, Weishaar ME: Schema Therapy: A Practitioner's Guide. New York, Guilford Press, 2003.
© 2014 S. Karger GmbH, Freiburg
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.